- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02061501
Evaluation of the Efficacy of Optometric Rehabilitation on Visual Cognitive Deficits in Children
Visual cognitive deficits in children are frequent, with an impact on working and daily activities. Optometric therapy may improve those functions, however few studies have been performed.
We aim to evaluate the efficacy of such therapy by a comparative study between two groups of children aged between 5 and 12 after 6 months of rehabilitation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anne de Saint Martin, MD
- Phone Number: +33 03 88 12 83 28
- Email: anne.desaintmartin@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67098
- Recruiting
- CRTLA - Hôpital de Hautepierre- CHRU Strasbourg
-
Contact:
- Anne de Saint-Martin, MD
- Phone Number: +33 03 88 12 83 28
- Email: anne.desaintmartin@chru-strasbourg.fr
-
Principal Investigator:
- Anne de Saint-Martin, MD
-
Sub-Investigator:
- Claire de Sèze, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- visual cognitive deficits
- normal intelligence
Exclusion Criteria:
- cerebral palsy
- mental deficiency
- visual acuity deficit
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Speech therapy
Speech therapy (30 min per week) alone for the 6 first months.
Then speech therapy (30 min per week) and optometric therapy (30 min per week) for the 6 last months.
|
Optometric therapy during 6 months, once a week
|
Experimental: Speech therapy and optometric therapy
Speech therapy (30 min per week) and optometric therapy (30 min per week) for 12 months.
|
Optometric therapy once a week, during 12 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Calculation of a composite score at Visit 1
Time Frame: Visit 1 (6 months of rehabilitation)
|
The composite score is calculated from the results obtained at several neuropsychology and optometric tests. Basal score is calculated at Visit 0 (inclusion visit). |
Visit 1 (6 months of rehabilitation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Calculation of a composite score at Visit 2
Time Frame: Visit 2 (12 months of rehabilitation)
|
The composite score is calculated from the results obtained at several neuropsychology and optometric tests.
|
Visit 2 (12 months of rehabilitation)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life
Time Frame: Visit 2 (12 months of rehabilitation)
|
Quality of life assessed by a questionnaire at V0, V1 and V2.
|
Visit 2 (12 months of rehabilitation)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5542
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Cognitive Deficits
-
Poznan University of Physical EducationCompletedMenopause | Cognitive Deficits, MildPoland
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
AbbVie (prior sponsor, Abbott)CompletedCognitive Deficits in SchizophreniaUnited States
-
AbbVie (prior sponsor, Abbott)CompletedCognitive Deficits in SchizophreniaUnited States
-
National Institute of Mental Health (NIMH)University of PittsburghWithdrawnCognitive Deficits Related to Internet UseUnited States
-
US Department of Veterans AffairsCompletedVisual And Cognitive DisabilityUnited States
-
University of Illinois at Urbana-ChampaignCompletedCognitive Change | Processing, Visual SpatialUnited States
-
FH Joanneum Gesellschaft mbHAustrian Research Promotion AgencyRecruiting
-
University of MichiganRecruiting
-
Zealand University HospitalCompleted
Clinical Trials on Optometric therapy during 6 months
-
Dream PlusCompletedAndrogenic AlopeciaKorea, Republic of
-
ProbiSearch SLCasen Recordati S.L.CompletedAcute Otitis MediaSpain
-
Assistance Publique - Hôpitaux de ParisCompletedInfantile Spinal Muscular Atrophy of Type 2 or 3France
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR); Simon Fraser UniversityActive, not recruitingBorderline Personality DisorderCanada
-
Pontificia Universidad Catolica de ChileUniversity Diego PortalesNot yet recruitingBorderline Personality DisorderChile
-
Salus UniversityUnknownConvergence InsufficiencyUnited States
-
Centre Hospitalier Universitaire de NiceCompletedDiabetic NephropathyFrance
-
University of KonstanzvivoTerminatedDepression | Posttraumatic Stress Disorder | Narrative Exposure Therapy | Interpersonal Psychotherapy
-
University of North Carolina, Chapel HillDuke University; Blue Cross Blue Shield of North Carolina; UNC Health AllianceActive, not recruiting
-
International Food Policy Research InstituteInstitut de Recherche pour le Developpement; Implementation management committee...Completed